Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease

Clinical Biochemistry

Volumn 34, Issue 4, 2001, Pages 309-315

  Haidari, Mehran ^a,b   Javadi, Ebrahim ^a   Sadeghi, Behnam ^a   Hajilooi, Mehrdad ^a   Ghanbili, Jafar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

C reactive protein; Coronary artery disease; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; CORRELATION FUNCTION; DEVELOPING COUNTRY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; C-REACTIVE PROTEIN; CONSTRICTION, PATHOLOGIC; CORONARY DISEASE; FEMALE; HUMANS; IMMUNOASSAY; INFLAMMATION; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX FACTORS;

EID: 0034964767     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00227-2     Document Type: Article

References (57)

1. The recent decline in mortality from coronary heart disease, 1980-1990;The effect of secular trends in risk factors and treatment
2. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators
3. Lifetime risk of developing coronary heart disease
4. Alternative projections of mortality and disability by cause 1990-2020;Global Burden of Disease Study
5. The genetic basis of atherosclerosis
6. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
7. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon
8. Elevation of C-reactive protein in 'active' coronary artery disease
9. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction
10. Inflammation in plaque rupture: An active participant or an invited guest?
11. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein
12. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
13. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
14. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide
15. C-Reactive protein induced agglutination of lipid suspensions prepared in the presence, and absence of phosphatidylcholine
16. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
17. C-reactive protein fifty years on
18. Interactions of C-reactive protein with the first component of human complement
19. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
20. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis
21. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in myocardial infarction
22. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
23. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
24. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
25. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
26. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
27. Markers of inflammation as predictors in cardiovascular disease
28. Atherosclerosis-an inflammatory disease
29. C-Reactive Protein, and Cardiovascular Risk. Has the Time Come for Screening the General Population?
30. Unstable angina. A classification
31. Selective coronary arteriography. I. A percutaneous transfemoral technic
32. Serum C-reactive protein, and fibrinogen concentrations, and self-reported angina pectoris, and myocardial infarction: Findings from National Health, and Nutrition Examination Survey III
33. Repeatability and validity of the Rose questionnaire for angina pectoris in the Atherosclerosis Risk in Communities Study
34. International diagnostic criteria for acute myocardial infarction and acute stroke
35. Methods for voluntary weight loss, control. Proceedings of NIH Technology Assessment Conference
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
37. New international reference preparation for proteins in human serum (RPPHS)
38. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease
39. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, treatment of high blood cholesterol in adults
40. The prevalence of coronary artery disease in an urban population in Isfahan, Iran
41. Inflammatory markers in men with angiographically documented coronary heart disease
42. C-Reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes
43. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
44. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
45. C-reactive protein, and other markers of inflammation in the prediction of cardiovascular disease in women
46. C-reactive protein adds to the predictive value of total, and HDL cholesterol in determining risk of first myocardial infarction
47. Serum C-reactive protein, and fibrinogen concentrations, and self-reported angina pectoris, and myocardial infarction: Findings from National Health, and Nutrition Examination Survey III
48. C-reactive protein: Relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
49. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
50. Interleukin-6, and the acute phase response
51. C-reactive protein concentration in children: Relationship to adiposity and other cardiovascular risk factors
52. Inflammation, obesity, stress, and coronary heart disease: Is interleukin-6 the link?
53. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
54. Production of C-reactive protein and risk of coronary events in stable and unstable angina
55. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
56. The primary prevention of myocardial infarction
57. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels